| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0054 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.0084 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |